Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

NCT01065662 is registered in ClinicalTrials.gov with Susana M. Campos, MD as lead sponsor.

NCT NCT01065662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01065662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Lead sponsor
Susana M. Campos, MD
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2010
Completion date
March 31, 2021
Enrollment
11 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, fallopian tube cancer, ovarian cancer, peritoneal cancer